Study guide
19.3 Left Atrial Appendage Closure
ARRT Cardiac-Interventional Radiography CI
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Structured Education & Clinical Experience 1.3 Content Outline & Study Plan
2 Patient Communication & Assessment
2.1 Pre-, Intra-, and Postprocedure Communication 2.2 History, Allergies, Medications & Team Communication 2.3 Screening, NPO, Education & Consent
3 Positioning, Access Assessment & Labs
3.1 Positioning & Vascular Access Assessment 3.2 Chemistry & Hematology Labs 3.3 Coagulation Studies & Arterial Blood Gas
4 Monitoring, Documentation & Contrast
4.1 Physiologic Monitoring in the Cath Lab 4.2 Support Equipment & Procedure Documentation 4.3 Contrast Agents, Indications & Contraindications
5 Medications & Sterile Technique
5.1 Anticoagulants, Antiplatelets & Thrombolytics 5.2 Vasoactives, Sedation & Emergency Medications 5.3 Asepsis, Sterile Technique & Hazardous Materials
6 Emergency Care
6.1 Contrast Reactions & Contrast-Induced Nephropathy 6.2 Cardiac Emergencies (MI, CHF, Arrhythmia, Tamponade, Shock) 6.3 Access-Site & Vascular Emergencies
7 Image Acquisition & Processing
7.1 Fluoroscopy Dose Rates & Pulse Modes 7.2 Digital Acquisition, Roadmapping & Projections 7.3 Post-Processing, Reconstruction & PACS
8 Injectors, Intravascular Imaging & Radiation Protection
8.1 Automatic Pressure Injectors 8.2 Ultrasound, IVUS, OCT & ICE Equipment 8.3 Patient Radiation Protection 8.4 Personnel ALARA, Monitoring & QC
9 Diagnostic Foundations
9.1 Cardiac Anatomy & Pathophysiology 9.2 Right & Left Heart Hemodynamics 9.3 Coronary Angiography, Dominance & Projections
10 Additional Diagnostic Imaging
10.1 Graft, Pulmonary, Aortic & Ventricular Angiography 10.2 ICE, Intravascular Imaging & Endomyocardial Biopsy 10.3 Flow Reserve (FFR, iFR, RFR)
11 Access Angiography & Hemodynamic Calculations
11.1 Peripheral & Access-Site Angiography 11.2 Stroke Volume & Cardiac Output (Fick, Thermodilution, Angiographic) 11.3 Valve Area (Gorlin, Hakki) & Shunt Calculations
12 Electrophysiology
12.1 Arrhythmia Detection & Cardioversion 12.2 Ablation for AF, Atrial Flutter & VT 12.3 Permanent, Temporary, Leadless & Biventricular Pacemakers 12.4 ICD Insertion & Lead Extraction
13 Access, Equipment & Closure
13.1 Access Methods & Ultrasound Guidance 13.2 Sheaths, Catheters, Guidewires & Manifold 13.3 Closure Devices, Pressure & Dressings
14 Suite Design & Procedure Complications
14.1 Interventional Suite & Hybrid OR 14.2 Recognition & Treatment of Procedure Complications
15 Percutaneous Intervention Basics
15.1 Coronary & Peripheral Angioplasty 15.2 Coronary & Peripheral Stent Placement 15.3 Coronary & Peripheral Atherectomy
16 Adjunctive PCI & Retrieval
16.1 Mechanical, Pharmacologic & Aspiration Thrombectomy 16.2 IVC Filters & Foreign-Body Retrieval 16.3 Pericardiocentesis
17 Mechanical Support & Advanced Devices
17.1 IABP & Catheter-Based Ventricular Assist Devices 17.2 ECMO, Intravascular Lithotripsy & Distal Embolic Protection
18 Structural Heart: Septal Defects & TAVR
18.1 PFO & ASD Closure 18.2 Ventricular Septal Defect Closure 18.3 TAVI/TAVR
19 Structural Heart: Valvuloplasty, TMVR & LAA
19.1 Valvuloplasty 19.2 Transcatheter Mitral Valve Repair 19.3 Left Atrial Appendage Closure
19.3 Left Atrial Appendage Closure
Key Takeaways Explain This Topic AI
Watchman-class and Amulet-class LAA occluders are for selected AF patients who need an alternative to long-term anticoagulation.
TEE or CT sizes the ostium and depth and must exclude LAA thrombus before you go left-sided.
Access is femoral venous then transseptal, guided by TEE or ICE; the device lands in the LAA ostium/landing zone and is tug-tested for stability.
Peri-device leak is a TEE color-Doppler finding; significant leak leaves residual embolic risk.
Classic Watchman warfarin-plus-aspirin then DAPT then aspirin is an example protocol, not an ARRT mandate; disasters are tamponade, device embolization, stroke, and vascular injury.
Last updated: August 2026
Left Atrial Appendage Closure
ARRT Cardiac-Interventional Procedures 2.B.6 is left atrial appendage (LAA) closure . The devices the R.T.(CI) will actually open are Watchman-class (single-lobe plug) and Amulet-class (lobe-and-disk) occluders. This is not a PFO double-disk (18.1), not a mitral clip (19.2), and not BAV. The Focus of Questions still applies: anatomy and pathophysiology , indications , contraindications , imaging , access , ultrasound , equipment , complications , and closure .
Quick Answer: LAA closure is for AF patients who need an alternative to long-term anticoagulation . TEE or CT sizes the appendage and excludes thrombus . Access is femoral venous then transseptal , guided by ICE or TEE . Land in the LAA ostium / landing zone , confirm with a tug test , and look for peri-device leak . A classic Watchman sequence of warfarin plus aspirin, then DAPT, then aspirin is an example protocol, not an ARRT mandate . Disasters: pericardial effusion/tamponade , device embolization , stroke , vascular injury.
Anatomy, pathophysiology, indication, contraindication
The LAA is a trabeculated outpouching of the LA — windsock, chicken-wing, cauliflower, or cactus in CT/TEE slang. In nonvalvular atrial fibrillation , the appendage is the dominant site of LA thrombus that later embolizes as ischemic stroke. Oral anticoagulation (warfarin or a DOAC) is first-line stroke prevention when the stroke-risk score warrants it. Percutaneous LAA closure is for the patient who needs an alternative to long-term anticoagulation : prior major bleeding, high bleeding risk, labile INR with inability to use a DOAC, or another documented reason the heart team will not commit to lifelong OAC. It is not a toy for every AF ablation, and it is not indicated to stop anticoagulation in a patient who is doing fine on a DOAC with no bleeding story.
Contraindications / stops: thrombus already in the LAA (do not implant on clot), an appendage too small or too shallow for available devices, anatomy no device will seal (some chicken-wing necks), active endocarditis or bacteremia, a contraindication to the planned post-implant antithrombotic window (even a short one), and no echo/CT roadmap. Valvular AF with a mechanical mitral prosthesis is a different anticoagulation problem — an LAA plug does not cancel a mechanical-valve warfarin indication.
Imaging, sizing, thrombus exclusion, ultrasound
Pre-procedure TEE or CT is how you size. TEE teaching sweeps 0°, 45°, 90°, and 135° to measure ostial width and depth; CT gives 3D ostium, landing-zone diameter, and the relationship to the pulmonary veins and circumflex. Do not invent unpublished ARRT millimeter cutoffs — match the measured landing zone to the labeled device chart. Exclude thrombus on the same TEE or on a recent CT/TEE. Smoke (spontaneous echo contrast) is not the same as a formed thrombus, but a definite LAA thrombus is a stop : anticoagulate and restudy.
Intraprocedural imaging. TEE or ICE (or both) guides transseptal puncture, sheath depth in the LAA, device unfolding, compression, peri-device color leak, and a new pericardial effusion. Fluoroscopy in RAO/caudal teaching views shows the LAA outline after a gentle contrast injection; fluoro does not replace echo thrombus exclusion. Vascular ultrasound guides the femoral venous stick.
Access, equipment, landing, tug test
Access. Femoral venous (usually right) → RA → transseptal puncture into the LA → steer a dedicated delivery sheath into the LAA. Puncture location is typically more inferior and posterior than a mitral-clip puncture so the sheath points at the appendage rather than the mitral valve. This is not arterial Watchman, and it is not “cross a PFO instead of puncturing.” Heparin after the LA is entered; ACT is lab protocol .
Watchman-class devices are a self-expanding nitinol frame with a fabric cover that sits in the landing zone at the LAA ostium, covering the mouth. After deployment, operators confirm position, compression of the frame (enough to hold, not so much the LAA tears), and a tug test : gentle traction on the delivery cable to prove the device is stable before release. Amulet-class devices use a lobe in the landing zone plus a disk that covers the ostium (dual-seal teaching). Know plug versus lobe-and-disk ; do not mix them up with an ASD occluder.
Peri-device leak is color Doppler around the fabric at the ostium. A significant leak is residual communication with the trabeculated LAA — residual embolic risk, and a reason not to stop the planned antithrombotic path. Historic Watchman teaching tolerated small leaks below a lab threshold (often discussed around 5 mm — lab teaching, not an unpublished ARRT cutoff ). Newer teaching prefers no leak . Either way, document the leak ; do not call a wide color jet a sealed appendage.
Antithrombotic example protocol — not an ARRT mandate
Endothelialization takes weeks to months. Until the fabric is covered, the device itself can form device-related thrombus (DRT) . Labs therefore prescribe a protocol-specific sequence.
Classic Watchman teaching (example only, not an ARRT mandate): warfarin plus aspirin for an early window (often taught as about 45 days ), then a TEE look for leak and DRT; if the seal is acceptable, transition to dual antiplatelet therapy , then aspirin long term. Some contemporary Watchman-class protocols use DAPT instead of warfarin from day one. Amulet-class programs often use DAPT then aspirin and may not mandate warfarin. Whatever the implanting service ordered is the regimen — the exam point is that some antithrombotic coverage continues after implant , not that you memorize an unpublished ARRT day-count. Do not tell a patient “the device means you never take a blood thinner again” on the table.
Complications and closure
Pericardial effusion / tamponade: the LAA wall is thin. Oversizing, deep sheath intubation, a wire perforation, or a rough transseptal produces bleeding into the pericardium. This can declare during the case or hours later . Echo now; pericardiocentesis ready; surgical backup if the hole is a torn appendage rather than a needle puncture. Chicken-wing and small-depth anatomy raise perforation risk when the sheath has nowhere to go.
Device embolization: undersized or poorly compressed device, released despite a failed tug test, or a shallow landing zone. The device may sit in the LA, LV, aorta, or beyond. This is a snare and surgical-backup problem, not “it will endothelialize wherever it landed.”
Stroke: missed LAA thrombus, air from sheath exchanges, debris, or later DRT if antithrombotics are skipped. Vascular complications are the large venous sheath (hematoma, fistula, rare AV fistula) plus any extra arterial line.
Closure of access is venous hemostasis (figure-of-8, manual pressure, venous closure device). Document distal pulses if an arterial line was also placed. Hybrid-OR backup is a local-program decision; tamponade and embolization still need an immediate echo-and-surgery path (14.1, 16.3).
Table: step / confirmation / disaster
- Step Confirmation Disaster if skipped
- Exclude thrombus TEE or CT: empty LAA Stroke from implanting on clot
Size ostium and depth TEE multiplane and/or CT vs device chart Undersize → embolization ; oversize → perforation
- Transseptal puncture TEE or ICE tenting; inferior-posterior for LAA Tamponade , aortic puncture
- Land in ostium / landing zone Position, compression, tug test Unstable device → embolization
- Seal Color Doppler peri-device leak Residual leak → residual embolic risk
- Aftercare Protocol antithrombotic; follow-up TEE DRT , bleeding, or premature OAC stop
- Worked case
A 78-year-old with nonvalvular AF, prior recurrent GI bleeding on a DOAC, CHA2DS2-VASc that would otherwise warrant anticoagulation. CT and TEE: no thrombus, landing zone matches a Watchman-class size. Femoral venous access, TEE-guided inferior-posterior transseptal , sheath into the LAA, device at the ostium, tug test holds, only a trivial peri-device leak. Start the lab’s antithrombotic protocol — if that lab uses classic Watchman teaching, that example is warfarin plus aspirin then a surveillance TEE, then DAPT, then aspirin; it is not an ARRT-mandated recipe . If TEE had shown LAA thrombus, stop . If the tug test fails and the frame rocks, do not release . Sudden hypotension with a new effusion is tamponade , not a vasovagal from the venous stick. A device that has left the LAA on the next fluoro is embolization — snare/surgery, not “check it in the morning.”
Exam traps
Closing an LAA that already contains thrombus .
Treating LAA closure as optional extra hardware on every AF ablation.
Skipping the tug test or ignoring a peri-device leak .
Reciting the classic Watchman warfarin–DAPT–aspirin sequence as an ARRT mandate rather than an example protocol .
Confusing Watchman/Amulet with a PFO/ASD double-disk or a MitraClip .
Calling tamponade impossible because the stick was venous.